Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
CVD Risk and Health in Postmenopausal Phytoestrogen Users
This study has been completed.
Study NCT00000613 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999 Last Updated: January 3, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Diseases
Cardiovascular Diseases
Coronary Disease
Depression
Heart Diseases
Myocardial Ischemia
Osteoporosis
Postmenopause
Additional conditions recognized in this trial
Coronary Artery Disease
Depressive Disorder
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Behavioral Symptoms
Bone Diseases, Metabolic
Mental Disorders
Mood Disorders
Musculoskeletal Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
dietary supplements
genistein
diet, soy proteins
More general drug interventions related to this trial
Anticarcinogenic Agents
Antineoplastic Agents
Enzyme Inhibitors
Estrogens
Estrogens, Non-Steroidal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Phytoestrogens
Protective Agents
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
